The continued high prevalence of HIV-associated neurocognitive disorders (HAND) remains a significant public health concern that is the focus of the HIV Neurobehavioral Research Center's Resource and Scientific Objectives. The Neurobehavioral (NB) Core is essential to the goals of the HNRC by providing state-of- the-art support to local, national, and international neuroAIDS studies that examine the prevalence, course, pathogenesis and treatment of HAND. In accordance with the HAND diagnostic guidelines, all participants in the HNRC cohort will undergo a comprehensive NB assessment that will include well-validated measures of neurocognitive functioning, psychiatric status, and everyday functioning. The NB Core's specific Resource Objectives are to provide: 1) demographically-adjusted individual, domain, and global summary scores of neurocognitive functioning across domains sensitive to HIV;2) Global and domain-specific determinations of NB change in individual participants using reliable and validated actuarial methods (e.g., regression-based norms for change);3) Self-assessment of cognitive and psychiatric symptoms and any reduced independence in daily functioning;4) Laboratory-based measures of everyday functioning (e.g., medication management);5) Current and lifetime history of mood and substance use diagnoses;6) Interdisciplinary case-conference consensus diagnoses of HAND;and 7) Technical assistance, training, certification, consultation, and career development mentoring. The Scientific Objectives of the NB Core are to support studies regarding the role of aging in the development and expression of HAND, the timing and determinants of HAND in acute and early HIV infection, and the effects of antiretroviral and other treatments for HAND. In particular, the NB Core seeks to support innovative studies that will enhance the classification accuracy (e.g., novel web-oriented tests) and clinical utility (e.g., brief, portable assessments) of everyday functioning assessments for diagnosing HAND. We will also continue to spearhead the development of the next generation of normative NB test standards for under-served populations in the U.S. and developing countries, including recently developed methods for detecting clinically meaningful NB change. The NB Core provides a resource for basic and clinical investigators interested in HAND, and is poised to respond quickly and flexibly to emergent scientific questions in neuroAIDS by providing access to valuable data, well-characterized participants, and expertise in the NB aspects of HIV infection.

Public Health Relevance

The Neurobehavioral Core enhances the public health relevance of the HNRC by providing neuroAIDS studies with important information on the neurocognitive, emotional, substance use, and daily functioning characteristics of the participants in HNRC cohort, along with training, mentoring, and consultation regarding the deployment, analysis, and interpretation of such applied, clinical neurobehavioral methods and data.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
5P30MH062512-14
Application #
8653608
Study Section
Special Emphasis Panel (ZMH1-ERB-M)
Project Start
Project End
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
14
Fiscal Year
2014
Total Cost
$105,054
Indirect Cost
$37,058
Name
University of California San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Babakhanyan, Ida; McKenna, Benjamin S; Casaletto, Kaitlin B et al. (2018) National Institutes of Health Toolbox Emotion Battery for English- and Spanish-speaking adults: normative data and factor-based summary scores. Patient Relat Outcome Meas 9:115-127
Moore, David J; Pasipanodya, Elizabeth C; Umlauf, Anya et al. (2018) Individualized texting for adherence building (iTAB) for methamphetamine users living with HIV: A pilot randomized clinical trial. Drug Alcohol Depend 189:154-160
Hoenigl, Martin; Moser, Carlee; Funderburg, Nicholas et al. (2018) Soluble Urokinase Plasminogen Activator Receptor (suPAR) is predictive of Non-AIDS Events during Antiretroviral Therapy-mediated Viral Suppression. Clin Infect Dis :
Hellmuth, Joanna; Milanini, Benedetta; Masliah, Eliezer et al. (2018) A neuropathologic diagnosis of Alzheimer's disease in an older adult with HIV-associated neurocognitive disorder. Neurocase 24:213-219
Lin, Timothy C; Dijkstra, Maartje; De Bree, Godelieve J et al. (2018) Brief Report: The Amsterdam Symptom and Risk-Based Score Predicts for Acute HIV Infection in Men Who Have Sex With Men in San Diego. J Acquir Immune Defic Syndr 79:e52-e55
MacDuffie, Katherine E; Brown, Gregory G; McKenna, Benjamin S et al. (2018) Effects of HIV Infection, methamphetamine dependence and age on cortical thickness, area and volume. Neuroimage Clin 20:1044-1052
Sundermann, Erin E; Heaton, Robert K; Pasipanodya, Elizabeth et al. (2018) Sex differences in HIV-associated cognitive impairment: an observational cohort study. AIDS :
Chow, Felicia C; Makanjuola, Akintomiwa; Wu, Kunling et al. (2018) Physical activity is associated with lower odds of cognitive impairment in women but not men living with HIV infection. J Infect Dis :
Jumare, Jibreel; El-Kamary, Samer S; Magder, Laurence et al. (2018) Plasma HIV RNA level is associated with neurocognitive function among HIV-1-infected patients in Nigeria. J Neurovirol 24:712-719
Namazi, Golnaz; Fajnzylber, Jesse M; Aga, Evgenia et al. (2018) The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies. J Infect Dis 218:1954-1963

Showing the most recent 10 out of 743 publications